1Sneed P, Mcdermott MW,Gutin P,etal. Interstitial brachytherapy procedures for brain tumors. Seminars in Surgical Oncology,1997,13:157-166.
2Gaspar LE,Zamorano, LJ,Shamsa F,et al. Permanent125Iodine implants for recurrentmalignant gliomas. Int J Radait Oncol Bio Phys, 1999,43:977-982.
3Halligan JB, Stelzer KJ, Rostomily RC et al. Operation and permanent lowactivity125I brachytherapy for recurrent high-grade astrocytomas.Int J Radait Oncol BioPhys,1996,35:541-547.
4Vikram B. Permanent Iodine-125 boost after teletherapy in primary cancer of thenasopharynx is safe and highly effective :long-term results. Int J Radait oncol Bio Phys,1997,38:1140.
6Matsumoto S, akeda M, Shibuya H, et a1. T1 and T2 squamous cell carcinomas of thefloor of the mouth: Results of brachytherapy mainly using198 Au grains. Int J Radait OncolBio Phys, 1996,34:833-841.
7Chen A, Galloway M, Landreneau R, et al. Introperative 125 I brachytherap forhigh-risk stage I non-small cell lung carcinoma. Int J Radait Oncol Bio Phys,1999,44:1057-1063.
8Peterz T, Nori D, Hilaris B, et al. Treatment of primary unresectable carcinoma ofthe pancreas with I-125 implantation. Int J Radait Oncol Bio Phys, 1989,17:931-935.
9Martinez-Monge R,Nag S,Edward W,et al125 I brachytherapy for colorectaladenocarcinona recurrent in the pelvia and paraortics. Int J Radait oncol BioPhya,1998,42:545-500.
10Storey MR,Landgren RC,Cottone JL, et al.Transperineal 12J Iodine im-plantation fortreatment of clinically localized prostate cancer:5-year tumor control and morbidity. IntJ Radait Oncol Bio Phys, 1999,43:565-570.
